Baylor College of Medicine

Company

Related News

Cocrystal, Nuvation, Nautilus Report Q1 2026 Results and Pipeline Advances

Cocrystal Pharma advanced CDI-988 in a Phase 1b norovirus study and received FDA Fast Track designation. Nuvation Bio reported $18.5 million in IBTROZI net product revenues and presented updated TRUST trial data. Nautilus Biotechnology progressed its proteomics platform toward commercialization, maintaining a cash runway through 2027.

New Research Highlights Combination Therapy and Molecular Pathways in Alzheimer's Disease

Two recent studies advance Alzheimer's research: one finds combining anti-amyloid antibodies with natural compounds improves efficacy and safety, while another maps a molecular cascade that could reveal new therapeutic targets. The combination therapy study used aducanumab, lecanemab, resveratrol, and curcumin. The molecular study identified gene expression networks and proposed a two-stage disease model.

Related Clinical Trials

NCT ID Title Status Phase
NCT07778823

Augmented Reality-Cardiopulmonary Resuscitation Support for Pediatric Resuscitation

RECRUITING NA
NCT07758114

Prenatal Education on Environmental Exposures During Pregnancy Study (PEEPS)

RECRUITING NA
NCT07744217

Identifying Biomarkers of Gastro Intestinal Comorbidities in Autism Spectrum Disorder

COMPLETED
NCT07730125

Gene-edited T Regulatory Cells (CRG-150) for the Treatment of Relapsed/Refractory Malignancies

NOT_YET_RECRUITING PHASE1/PHASE2
NCT07729397

Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)

NOT_YET_RECRUITING PHASE1
NCT07723937

GelPOINT® Path-Assisted Endoscopic Removal of Colon and Rectal Polyps: A Feasibility and Safety Study

RECRUITING
NCT07719088

Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life

NOT_YET_RECRUITING PHASE1
NCT07674628

SALUD-M: Acceptance Based Coping Skills for Hispanic/Latinx Military Patients With Type 2 Diabetes

RECRUITING NA
NCT07672418

Postoperative Pain After Pediatric Adenotonsillectomy With Ketorolac or Ibuprofen

NOT_YET_RECRUITING
NCT07544979

Creation of a Decision Aid for Coronary Anomalies

RECRUITING NA